Literature DB >> 16507896

Nerve damage in Mycobacterium ulcerans-infected mice: probable cause of painlessness in buruli ulcer.

Masamichi Goto1, Kazue Nakanaga, Thida Aung, Tomofumi Hamada, Norishige Yamada, Mitsuharu Nomoto, Shinichi Kitajima, Norihisa Ishii, Suguru Yonezawa, Hajime Saito.   

Abstract

Buruli ulcer is an emerging chronic painless skin disease found in the tropics and caused by Mycobacterium ulcerans; however, it remains unknown why the large and deep ulcers associated with this disease remain painless. To answer this question, we examined the pathology of BALB/c mice inoculated in the footpads with M. ulcerans African strain 97-107. On days 54 to 70 after inoculation, extensive dermal ulcers, subcutaneous edema, and numerous acid-fast bacilli were noted at the inoculate region. Nerve invasion occurred in the perineurium and extended to the endoneurium, and some nerve bundles were swollen and massively invaded by acid-fast bacilli. However, Schwann cell invasion, a characteristic of leprosy, was not observed. Vacuolar degeneration of myelin-forming Schwann cells was noted in some nerves which may be induced by mycolactone, a toxic lipid produced by M. ulcerans. Polymerase chain reaction analysis of microdissected nerve tissue sections showed positive amplification of M. ulcerans-specific genomic sequences but not of Mycobacterium leprae-specific sequences. Behavioral tests showed decrease of pain until edematous stage, but markedly ulcerated animals showed ordinary response against stimulation. Our study suggests that the painlessness of the disease may be partly due to intraneural invasion of bacilli. Further studies of nerve invasion in clinical samples are urgently needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16507896      PMCID: PMC1606540          DOI: 10.2353/ajpath.2006.050375

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

Review 1.  Mycobacterium ulcerans infection.

Authors:  T S van der Werf; W T van der Graaf; J W Tappero; K Asiedu
Journal:  Lancet       Date:  1999-09-18       Impact factor: 79.321

2.  Transmission of Mycobacterium ulcerans to the nine-banded armadillo.

Authors:  D S Walsh; W M Meyers; R E Krieg; G P Walsh
Journal:  Am J Trop Med Hyg       Date:  1999-11       Impact factor: 2.345

3.  Peripheral nerve granuloma in a patient with tuberculosis.

Authors:  R W Orrell; R H M King; J V Bowler; L Ginsberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

4.  In vitro activity of KRM-1648, either singly or in combination with ofloxacin, against Mycobacterium ulcerans.

Authors:  A M Dhople
Journal:  Int J Antimicrob Agents       Date:  2001-01       Impact factor: 5.283

5.  Clinico-histopathological findings of Buruli ulcer.

Authors:  M Mwanatambwe; Y Fukunishi; M Yajima; K Suzuki; K Asiedu; S Etuafel; N Yamada; G Asano
Journal:  Nihon Hansenbyo Gakkai Zasshi       Date:  2000-07

6.  [A morphological study of nerve biopsies in leprous neuropathy].

Authors:  T Kimura
Journal:  Nihon Hansenbyo Gakkai Zasshi       Date:  2001-08

7.  Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae.

Authors:  V Ng; G Zanazzi; R Timpl; J F Talts; J L Salzer; P J Brennan; A Rambukkana
Journal:  Cell       Date:  2000-10-27       Impact factor: 41.582

8.  Mycobacterium leprae typing by genomic diversity and global distribution of genotypes.

Authors:  M Matsuoka; S Maeda; M Kai; N Nakata; G T Chae; T P Gillis; K Kobayashi; S Izumi; Y Kashiwabara
Journal:  Int J Lepr Other Mycobact Dis       Date:  2000-06

9.  Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.

Authors:  Herve Dega; Abdelhalim Bentoucha; Jerome Robert; Vincent Jarlier; Jacques Grosset
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

10.  Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice.

Authors:  A Bentoucha; J Robert; H Dega; N Lounis; V Jarlier; J Grosset
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

View more
  19 in total

Review 1.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

Review 2.  Infection, Pain, and Itch.

Authors:  Isaac M Chiu
Journal:  Neurosci Bull       Date:  2017-01-31       Impact factor: 5.203

Review 3.  Bacterial Signaling to the Nervous System through Toxins and Metabolites.

Authors:  Nicole J Yang; Isaac M Chiu
Journal:  J Mol Biol       Date:  2017-01-06       Impact factor: 5.469

4.  Scalable and efficient synthesis of the mycolactone core.

Authors:  Katrina L Jackson; Wenju Li; Chi-Li Chen; Yoshito Kishi
Journal:  Tetrahedron       Date:  2010-03-27       Impact factor: 2.457

5.  A need for null models in understanding disease transmission: the example of Mycobacterium ulcerans (Buruli ulcer disease).

Authors:  Joseph P Receveur; Alexandra Bauer; Jennifer L Pechal; Sophie Picq; Magdalene Dogbe; Heather R Jordan; Alex W Rakestraw; Kayla Fast; Michael Sandel; Christine Chevillon; Jean-François Guégan; John R Wallace; M Eric Benbow
Journal:  FEMS Microbiol Rev       Date:  2022-01-18       Impact factor: 15.177

Review 6.  Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.

Authors:  Caroline Demangel; Timothy P Stinear; Stewart T Cole
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

Review 7.  The chemistry and biology of mycolactones.

Authors:  Matthias Gehringer; Karl-Heinz Altmann
Journal:  Beilstein J Org Chem       Date:  2017-08-11       Impact factor: 2.883

8.  Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study.

Authors:  Junichiro En; Masamichi Goto; Kazue Nakanaga; Michiyo Higashi; Norihisa Ishii; Hajime Saito; Suguru Yonezawa; Hirofumi Hamada; Pamela L C Small
Journal:  Infect Immun       Date:  2008-03-03       Impact factor: 3.441

9.  Experiences of Pain and Expectations for Its Treatment Among Former Buruli Ulcer Patients.

Authors:  Rebecca J Woolley; Anita Velink; Richard O Phillips; William A Thompson; K Mohammed Abass; Tjip S van der Werf; Janine de Zeeuw; Ymkje Stienstra
Journal:  Am J Trop Med Hyg       Date:  2016-09-12       Impact factor: 2.345

10.  Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease.

Authors:  Fred Stephen Sarfo; Paul J Converse; Deepak V Almeida; Jihui Zhang; Clive Robinson; Mark Wansbrough-Jones; Jacques H Grosset
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.